Chemical Structure : TrkC.T1 antagonist CP14
货号: PC-24089Not For Human Use, Lab Use Only.
Cyclic-14-KI (CP14) is a specific, noncompetitive and allosteric antagonist of TrkC truncated isoform TrkC.T1, selectively antagonize TrkC, reduces CP14 reduces the affinity of NT3 binds to TrkC.T1 with Kd of 11.5 nM.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Cyclic-14-KI (CP14) is a specific, noncompetitive and allosteric antagonist of TrkC truncated isoform TrkC.T1, selectively antagonize TrkC, reduces CP14 reduces the affinity of NT3 binds to TrkC.T1 with Kd of 11.5 nM.
Cyclic-14-KI (CP14) does not inhibit TrkC-FL/NT3 and does not affect the binding of PTPs to either isoform.
Cyclic-14-KI (CP14) blocks up-regulation of TNF-α mRNA, does not have any effect on receptor family members TrkA or TrkB that are activated by their respective ligands NGF or BDNF.
Cyclic-14-KI (CP14) decreases TNF-α protein and cell death in retinal explants of RHOP347S mice.
Cyclic-14-KI (CP14) decrease photoreceptor cell death in the RHOP347S mice retina in vivo.
分子量 | 489.57 | |
分子式 | C24H35N5O6 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Brahimi F, et al. PNAS Nexus. 2025 Feb 4;4(2):pgaf020.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright